Jul 20,2021

Aidence and Heart&Lung partner for Greater Manchester cancer screening

Medtech firm Aidence and Heart&Lung Health (H&L), a specialist in chest and cardiac radiology reporting, have partnered to provide AI-powered, scan reporting for lung cancer screening in Tameside, Glossop, and North Manchester Clinical Commission Groups (CCGs). The collaboration between Manchester University NHS Foundation Trust (MFT), Aidence, and H&L aims to ensure that no early-stage cancers are missed in the screening chest CT scans and that reporting follows the correct protocol and the highest clinical standards.

COLLABORATION PARTNERSHIP

#institution

#ai/software

View Analyst & Ambassador Comments
Go to original news
Dec 02,2021

Hardian and Aidence partner with University of Edinburgh for NHS AI Award

An innovative clinical evaluation programme has been launched to examine the impact of artificial intelligence (AI) on radiology decision making in the lung cancer pathway and the patient outcomes from these decisions. The programme, called INPACT, is a collaboration between MedTech scale-up Aidence, clinical consultancy Hardian Health, and the University of Edinburgh, with funding from the NHSX through the NHS AI in Health and Care Award. 

COLLABORATION PARTNERSHIP

#r&d

#ai/software

View Analyst & Ambassador Comments
Go to original news
Apr 07,2021

Aidence partners with the Netherlands Cancer Institute to leverage AI for lung cancer care

The Netherlands Cancer Institute (NKI), one of the world’s top 10 comprehensive cancer centres, is using artificial intelligence (AI) for lung nodule management. The AI solution, Veye Lung Nodules, is provided by MedTech scaleup Aidence. Veye Lung Nodules is a CE certified second or concurrent reader used in routine practice and lung cancer screening across Europe. At NKI, it will analyse over 15,000 chest CT scans per year, and the additional prior scans for approximately 80% of studies.

COLLABORATION PARTNERSHIP

#institution

#ai/software

View Analyst & Ambassador Comments
Go to original news
Dec 04,2019

Affidea partners with Aidence in lung cancer screening and diagnosis

As the leading European provider of advanced diagnostic imaging services, Affidea is starting the collaboration with Aidence, a medical artificial intelligence (AI) company that develops deep-learning solutions for healthcare, by implementing its AI solution Veye Lung Nodules on a ground-breaking pilot in three countries: Italy, Greece, and Hungary, with the possibility to extend it to other regions across Affidea’s European network.

COLLABORATION PARTNERSHIP

#institution

#ai/software

View Analyst & Ambassador Comments
Go to original news
Sep 24,2019

Tech startup Vizlitics is trying to democratize cancer care

At the HIMSS 2.0 Conference 2019, the CEO of Vizlitics Tarun Kumar shares the insights from the company's first product Cancer Insights in an interview.

PRODUCT

#mobile app

#rpm

View Analyst & Ambassador Comments
Go to original news
Nov 23,2020

Bayer Initiates New G4A Digital Health Partnerships Program

Bayer will support five new startup companies as part of the company's G4A Digital Health Partnerships Program. Focus will be on fostering the development of a digital health ecosystem, while driving forward integrated healthcare solutions in the fields of cardiometabolic and renal diseases, oncology, and women's health. Bayer's G4A partnership program offers two digital health collaboration segments. Under its Growth Track, selected early-stage startups including ELLY Health receive EUR 100.000 funding to accelerate market uptake, coaching by Bayer executives, and tailored business acceleration clinics.

COLLABORATION PARTNERSHIP

#product & service

#mobile app

View Analyst & Ambassador Comments
Go to original news
Mar 03,2020

Sema4 and VieCure collaborate to provide real-time patient insights

Health intelligence company Sema4 and artificial intelligence (AI) informatics company VieCure have entered a strategic collaboration to enable oncologists to provide personalised care to the patients. The alliance allows Sema4 scientists to access patient data from the VCurePrecision EMR platform with the consent of the patients and analyse the data using its Centrellis health intelligence platform. Furthermore, it will allow oncologists using the VCurePrecision EMR to access real-time insights that help in point-of-care decision-making and clinical trial identification for patients. This strategic collaboration also enables healthcare providers to recommend Sema4’s molecular testing for cancer through the VCurePrecision platform.

COLLABORATION PARTNERSHIP

#data & technology

#rwd

#rwe

View Analyst & Ambassador Comments
Go to original news
Dec 19,2022

The Postgraduate Institute for Medicine and VieCure Announce a Partnership to Provide CME to Users of the VieCure Platform through Internet Search and Learn

The Postgraduate Institute for Medicine (PIM), which accredits more than 2,500 educational activities for healthcare professionals each year, and VieCure, a cancer care company with a powerful clinical decision support platform, are pleased to announce a new partnership designed to offer continuing medical education (CME) to the multidisciplinary cancer care teams utilizing the VieCure platform. Beginning in January 2023, VieCure users will be eligible to earn 0.5 AMA PRA Category 1 Credit™ for each internet search and learn session they perform.

COLLABORATION PARTNERSHIP

#institution

#ai/software

View Analyst & Ambassador Comments
Go to original news
Jan 25,2023

VieCure, Labcorp collaborate on clinical workflows, genomic testing

VieCure on Wednesday announced a collaboration with Labcorp to increase clinicians’ access to decision-support for precision oncology. The firms are aiming to assist patient-specific treatment plans by integrating Labcorp’s precision medicine testing with VieCure’s clinical decision-support tool. By doing so, they plan to enable community cancer care providers to increase precision diagnostic test utilization for cancer patients, including those living in rural and remote areas who may lack access to larger oncology centers.

COLLABORATION PARTNERSHIP

#connected device

#ai/software

#platform

View Analyst & Ambassador Comments
Go to original news
Aug 09,2022

VieCure Partners with Clarified Precision Medicine to Accelerate the Adoption of Precision Oncology

VieCure, a cancer care company with a market leading artificial intelligence, informatics, and clinical decision support platform, announced today a new strategic collaboration with Clarified Precision Medicine which will make precision oncology more accessible for patients and community oncologists. VieCure will fully integrate the Clarified Precision Medicine Somatic and Germline Clinical Consultation process within its A.I. platform and offer community oncologists with streamlined access to Clarified’s nationally recognized test interpretation team.

COLLABORATION PARTNERSHIP

#connected device

#ai/software

#platform

View Analyst & Ambassador Comments
Go to original news
Subscribe to ONCOLOGY